Cutera said that Health Canada has expanded approval for its truSculpt iD body sculpting treatment to cover its use for the reduction of circumference of the abdomen and non-invasive lipolysis, which…
Rozlytrek FDA approval : Roche’s subsidiary Genentech has bagged approvals for Rozlytrek (entrectinib) from the US Food and Drug Administration (FDA) for a type of non-small cell lung cancer (NSCLC)…
Nucala FDA approval : GlaxoSmithKline (GSK) has secured approval from the US Food and Drug Administration (FDA) for Nucala (mepolizumab) for the treatment of severe eosinophilic asthma in children, aged…
US precision medicine company Gemini Therapeutics, which is focused on developing treatments for age-related macular degeneration (AMD) and linked ocular disorders, has appointed Jason Meyenburg as its Chief Executive Officer…
Castle Creek acquisition of Fibrocell : Castle Creek Pharmaceutical Holdings (CCP Holdings) has agreed to acquire Fibrocell Science, a cell and gene therapy company engaged in developing autologous cell-based therapies…
FeDeriCa clinical trial results : Roche’s Genentech reported that the phase 3 FeDeriCa study evaluating the investigational fixed-dose combination (FDC) of Perjeta (pertuzumab) and Herceptin (trastuzumab) with hyaluronidase in HER2-positive…
Cutera truSculpt iD body sculpting treatment gets expanded approval in Canada
Cutera said that Health Canada has expanded approval for its truSculpt iD body sculpting treatment to cover its use for the reduction of circumference of the abdomen and non-invasive…
CroíValve set to advance Tricuspid Coaptation Valve into clinical trial
CroíValve, an Irish medtech company spun out from Trinity College, has raised €4 million for developing a medical device called Tricuspid Coaptation Valve for the treatment of tricuspid…
Equashield CSTD now available for oncology nurses in Japan
US medical device company Equashield through Japanese distributor Tosho has entered into an exclusive agreement with IV tube manufacturer PAL Medical to provide Equashield’s Closed System Transfer Devices…
OncoCyte to acquire Razor Genomics to advance lung cancer diagnosis
OncoCyte acquisition of Razor Genomics : US diagnostic tests developer OncoCyte has agreed to acquire Razor Genomics, a provider of molecular diagnostic testing services for lung cancer. Initially,…
Gemini Therapeutics appoints Jason Meyenburg as CEO
US precision medicine company Gemini Therapeutics, which is focused on developing treatments for age-related macular…
Castle Creek to acquire cell and gene therapy company Fibrocell
Castle Creek acquisition of Fibrocell : Castle Creek Pharmaceutical Holdings (CCP Holdings) has agreed to…
Aytu BioScience to acquire Innovus Pharmaceuticals
Aytu acquisition of Innovus : Colorado-based specialty pharma company Aytu BioScience has agreed to acquire…
Mallinckrodt to sell Canadian CDMO BioVectra to H.I.G. Capital for $250m
Mallinckrodt sale of BioVectra to H.I.G. Capital : Irish biopharma company Mallinckrodt has agreed to…
BioMed, University of California open cancer research center in San Diego
The University of California San Diego (UC San Diego) and BioMed Realty have opened the…
Sumitomo Dainippon Pharma to buy into Roivant Sciences Vants for $3bn
Sumitomo Dainippon Pharma has signed a deal worth $3 billion to assume ownership of stakes…
Maruho, X-Chem collaborate to advance drug discovery
X-Chem, a US biotech company, has entered into a drug discovery partnership with Japanese dermatology…
Latest Pharma News
-
Cutera truSculpt iD body sculpting treatment gets expanded approval in Canada
-
Genentech bags Rozlytrek FDA approval for two rare types of cancer
-
GSK bags Nucala FDA approval for severe eosinophilic asthma in 6-11 years age group
-
Gemini Therapeutics appoints Jason Meyenburg as CEO
-
Castle Creek to acquire cell and gene therapy company Fibrocell
-
FeDeriCa clinical trial results : Phase 3 trial in HER2-positive breast cancer meets primary endpoint
-
Eisai, Biogen to scrap elenbecestat phase 3 studies in early AD
-
CANDOR clinical trial results : Amgen’s Kyprolis extends PFS in multiple myeloma patients
-
RESTORE clinical trial of STR001 : Strekin completes patient enrollment
-
CroíValve set to advance Tricuspid Coaptation Valve into clinical trial
